Literature DB >> 24100800

Abdominopelvic tuberculosis mimicking advanced ovarian cancer and pelvic inflammatory disease: a series of 28 female cases.

Qi Liu1, Qin Zhang, Qun Guan, Jin-feng Xu, Qun-li Shi.   

Abstract

OBJECTIVE: To present and discuss 28 female cases with abdominopelvic tuberculosis (TB) and abnormal CA125 levels to better distinguish this disease from advanced ovarian cancer (AOC) and pelvic inflammatory disease (PID). Abdominopelvic tuberculosis (APTB) is one of the extrapulmonary tuberculosis (TB) sites, usually misdiagnosed as AOC and PID and then has to undergo surgery. However, the treatment of APTB is totally based on medical therapy other than surgery except biopsy. This article aims to present and discuss 28 female APTB cases with abnormal CA125 levels to better distinguish this disease from AOC and PID so as to find out non-invasive APTB diagnosis methods.
METHODS: 28 APTB patients diagnosed between January 2000 and January 2010 in our gynecologic department of Nanjing Jinling hospital were reviewed retrospectively and compared with AOC and PID.
RESULTS: The mean age was 38.24 ± 11 (range 15-64) years. Elevated levels of serum CA125 were determined in all 28 patients (100%). Other common findings were ascites in 20 (71.43%, 20/28), pelvic mass in 21(75%, 21/28), slight fever with night sweat in 13 (46.43%, 13/28), cough and pleural effusion in nine (32.14 %, 9/28), high fever more than 39 °C combined with abdominal pain and elevated white blood count in five (17.86%, 5/28), weight loss more than 5 kg at admission in six (21.43%, 6/28). Diagnoses were made based on biopsy from laparotomy in 14 (50%) patients, from laparoscopy in nine (32.14%), from diagnostic curettage because of primary infertility in two (7.14%), and only from clinical suspicion in three patients. Histopathology revealed that caseating granulomatous lesions were seen in 25 patients, positive anti-acid staining in 11 patients. Totally 26 patients completed anti-TB therapy successfully and were cured, two patients died of the disease because of long-term immune inhibitor used.
CONCLUSION: Although it is difficult to exactly distinguish APTB from AOC and PID without operation, it is important because the treatment of APTB is totally based on medical therapy other than surgery. Some difference may be found out if clinical manifestation, physical examination, laboratory tests and imaging findings are carefully analyzed to avoid unnecessary extensive surgery and improve the prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100800     DOI: 10.1007/s00404-013-3034-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Abdominopelvic Tuberculosis Secondary to a Nontuberculous Mycobacterium in an Immunocompetent Patient.

Authors:  Beng Kwang Ng; Kembang Aziah Yakob; Wendy Yin Ling Ng; Pei Shan Lim; Rahana Abd Rahman; Abdul Kadir Abdul Karim; Ani Amelia Zainuddin; Zaleha Abdullah Mahdy
Journal:  Case Rep Med       Date:  2017-11-13

2.  Abdominopelvic Tuberculosis with a Frozen Section Analysis Consistent with Ovarian Cancer.

Authors:  Agrimaldo Martins-Filho; Paula Carolina Arvelos Crispim; Renata Margarida Etchebehere; Cristina da Cunha Hueb Barata de Oliveira; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini
Journal:  Case Rep Infect Dis       Date:  2017-04-09

3.  Infectious diseases mimicking ovarian carcinomatosis.

Authors:  Sara M Drayer; Jessica J Shank
Journal:  Gynecol Oncol Rep       Date:  2018-08-28

4.  Extrapulmonary Tuberculosis Mimics Diffuse Metastatic Disease: A Case Report.

Authors:  Gulgun Engin; Kızıldag Yirgin; Hulya Kandemir
Journal:  Indian J Radiol Imaging       Date:  2021-12-13

5.  First case of human peritoneal cysticercosis mimicking peritoneal carcinosis: necessity of laparoscopy and histologic assessment for the correct diagnosis.

Authors:  Martina Rudelius; Klaus Brehm; Martin Poelcher; Christoph Spinner; Andreas Rosenwald; Clarissa Prazeres da Costa
Journal:  JMM Case Rep       Date:  2017-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.